CCDR: Vol. 46 No. 5-May 2020: Nosocomial infection surveillance

Table of contents

Surveillance
Healthcare-associated infections and antimicrobial resistance in Canadian acute care hospitals, 2014–2018
Canadian Nosocomial Infection Surveillance Program

Best practice
Canadian Public Health Laboratory Network Best Practices for COVID-19
Respiratory Virus Infections Working Group

Advisory Committee Statement
Canadian Public Health Laboratory Network Statement on Point-of-Care Serology Testing in COVID-19
Respiratory Virus Infections Working Group

Update
Laboratory-confirmed COVID-19 in children and youth in Canada, January 15–April 27, 2020
D Paquette, C Bell, M Roy, L Whitmore, A Currie, C Archibald, D MacDonald, J Pennock

Overview
Modified two-tiered testing algorithm for Lyme disease serology: the Canadian context
T Hatchette, R Lindsay on behalf of the Lyme Disease Diagnostics Working Group

Advisory Committee Statement
Summary of the NACI Seasonal Influenza Vaccine Statement for 2020–2021
K Young, I Gemmill, R Harrison on behalf of the National Advisory Committee on Immunization (NACI)

Survey report
National findings from the Tracks survey of people who inject drugs in Canada, Phase 4, 2017–2019
J Tarasuk, J Zhang, A Lemyre, F Cholette, M Bryson, D Paquette

Infographic
Determinants of HIV and hepatitis C among people who inject drugs in Canada, 2017–2019

Rapid communication
Surveillance of persons who tested negative for COVID-19 in Ontario, January 22–February 22, 2020
M Murti, M Whelan, A Saunders, K Hohenadel, J Gubbay, S Buchan

Series
Vaccine acceptance: How to build and maintain trust in immunization
C Sondagar, R Xu, NE MacDonald, E Dubé